Healthcare Resource Utilization and Costs of Multiple Sclerosis in Canada by Disability (P3.405)

Conclusions:Healthcare resource utilization remains high in MS. The annualized utilization and costs for each resource type will be presented by disability level.Study Supported by: Alberta Health and Roche CanadaDisclosure: Dr. Metz has received research support from Roche. Dr. Greenfield has nothing to disclose. Dr. Marrie has received research support from Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada, National Multiple Sclerosis Society, Rx & D Health Research Foundation, Research Manitoba, Crohn's and Colitis Canada and Sanofi-Aventis. Dr. Jette has nothing to disclose. Dr. Suchowersky has received personal compensation for activities with AbbVie and IPSEN as a consultant. .Dr. Suchowersky received research support from Abbvie and Biotie. Dr. Svenson has nothing to disclose. Dr. Alikhani has nothing to disclose. Dr. Khan has nothing to disclose. Dr. Gholizadeh has received personal compensation for activities with Roche Canada as an employee. Dr. Xue has received personal compensation for activities with Roche Canada as an employee.
Source: Neurology - Category: Neurology Authors: Tags: Economic Implications of Multiple Sclerosis Source Type: research